N
ORGS

Nuveen’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Nuveen’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,955
Closed -$513K – 3564
2021
Q1 		$513K Sell
8,955
-554
-6% -$36.1K ﹤0.01% 3095
2020
Q4 		$428K Buy
9,509
+273
+3% +$13.2K ﹤0.01% 3075
2020
Q3 		$465K Buy
9,236
+1,388
+18% +$75.3K ﹤0.01% 2976
2020
Q2 		$477K Buy
+7,848
New +$475K ﹤0.01% 2921

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Nuveen's ORGS Position: Q2 2021 in Review

Nuveen sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 8,955 shares — an estimated $513K sold.

Nuveen first reported a position in ORGS in Q2 2020 and held it in 4 quarters. The position peaked at $513K in Q1 2021. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

  • Nuveen reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 8,955 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $513K.
  • Nuveen first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Nuveen's Orgenesis Inc. Common Stock position peaked at $513K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.